BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osuka S, Zhu D, Zhang Z, Li C, Stackhouse CT, Sampetrean O, Olson JJ, Gillespie GY, Saya H, Willey CD, Van Meir EG. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. J Clin Invest 2021;131:136098. [PMID: 33720050 DOI: 10.1172/JCI136098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Noronha C, Ribeiro AS, Taipa R, Castro DS, Reis J, Faria C, Paredes J. Cadherin Expression and EMT: A Focus on Gliomas. Biomedicines 2021;9:1328. [PMID: 34680444 DOI: 10.3390/biomedicines9101328] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Frosina G. Radiotherapy of High-Grade Gliomas: First Half of 2021 Update with Special Reference to Radiosensitization Studies. Int J Mol Sci 2021;22:8942. [PMID: 34445646 DOI: 10.3390/ijms22168942] [Reference Citation Analysis]
3 Miao YQ, Chen W, Zhou J, Shen Q, Sun Y, Li T, Wang SC. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner. Bioengineered 2022;13:1858-71. [PMID: 35012429 DOI: 10.1080/21655979.2021.2018386] [Reference Citation Analysis]
4 Vilar JB, Christmann M, Tomicic MT. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go? Cancers 2022;14:2416. [DOI: 10.3390/cancers14102416] [Reference Citation Analysis]